SCHEMBL31489686

SCHEMBL31489686

Clc1cncc(-c2cn[nH]c2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 7/20 0.44
▸ AKT2 P31751 3/20 0.44
▸ MAPK1 P28482 3/20 0.42
▸ CYP11B2 P19099 2/20 0.41
▸ CYP11B1 P15538 1/20 0.41
▸ ILK Q13418 1/20 0.40
▸ CD38 P28907 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ PRKD3 O94806 1/20 0.38
▸ PRKCG P05129 1/20 0.38
▸ PRKCB P05771 1/20 0.38
▸ BRAF P15056 1/20 0.38
▸ PRKCA P17252 1/20 0.38
▸ PRKCH P24723 1/20 0.38
▸ PRKCI P41743 1/20 0.38
▸ PRKCE Q02156 1/20 0.38
▸ PRKCQ Q04759 1/20 0.38
▸ PRKCZ Q05513 1/20 0.38
▸ PRKCD Q05655 1/20 0.38
▸ PRKD1 Q15139 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21861348 0.77 AKT1 (0.44) AKT1AKT2MAPK1ILKCD38
SCHEMBL13097161 0.77 AKT1 (0.44) AKT1AKT2MAPK1CYP11B2CYP11B1
SCHEMBL21193202 0.74 CYP11B2 (0.46) AKT1AKT2MAPK1CYP11B2CYP11B1
SCHEMBL6196346 0.74 — —
SCHEMBL1365945 0.74 AKT1 (0.48) AKT1AKT2MAPK1ILKPRKD3
SCHEMBL3740850 0.73 AKT2 (0.70) AKT1AKT2MAPK1ILK
SCHEMBL13086435 0.73 MAPK8 (0.43) AKT1AKT2MAPK1ILKCD38
Hydrochloric Acid SCHEMBL28973063 0.71 AKT2 (0.67) AKT1AKT2MAPK1ILK
SCHEMBL15574039 0.71 AKT2 (0.50) AKT1AKT2MAPK1ILKMAPT
SCHEMBL14941606 0.71 PIK3CD (0.52) AKT1AKT2MAPK1PRKD3PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 — — WO disclosed
Send feedback